These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30959762)

  • 1. Regulation of Noise-Induced Loss of Serotonin Transporters with Resveratrol in a Rat Model Using 4-[
    Li IH; Shih JH; Jhao YT; Chen HC; Chiu CH; Chen CF; Huang YS; Shiue CY; Ma KH
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the effects of noise-induced hearing loss on serotonin transporters in rat brain using 4-[18F]-ADAM/small animal PET.
    Kang HH; Wang CH; Chen HC; Li IH; Cheng CY; Liu RS; Huang WS; Shiue CY; Ma KH
    Neuroimage; 2013 Jul; 75():262-269. PubMed ID: 22766166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study.
    Shih JH; Ma KH; Chen CF; Cheng CY; Pao LH; Weng SJ; Huang YS; Shiue CY; Yeh MK; Li IH
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):92-104. PubMed ID: 26612383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of brain SERT with 4-[
    Liu CT; Huang YS; Chen HC; Ma KH; Wang CH; Chiu CH; Shih JH; Kang HH; Shiue CY; Li IH
    Toxicol Appl Pharmacol; 2019 Sep; 378():114604. PubMed ID: 31153898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study.
    Chen YA; Huang WS; Lin YS; Cheng CY; Liu RS; Wang SJ; Li IH; Huang SY; Shiue CY; Chen CY; Ma KH
    Nucl Med Biol; 2012 Feb; 39(2):279-85. PubMed ID: 22136885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET.
    Li IH; Huang WS; Shiue CY; Huang YY; Liu RS; Chyueh SC; Hu SH; Liao MH; Shen LH; Liu JC; Ma KH
    Neuroimage; 2010 Jan; 49(2):1259-70. PubMed ID: 19682588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography.
    Ma KH; Huang WS; Kuo YY; Peng CJ; Liou NH; Liu RS; Hwang JJ; Liu JC; Chen HJ; Shiue CY
    Neuroimage; 2009 Apr; 45(3):687-93. PubMed ID: 19211037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of serotonin transporters with 4-[18F]-ADAM in a Parkinsonian rat model.
    Weng SJ; Shiue CY; Huang WS; Cheng CY; Huang SY; Li IH; Tao CC; Chou TK; Liao MH; Chang YP; Ma KH
    Cell Transplant; 2013; 22(7):1295-305. PubMed ID: 23127756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 2-(2'-((dimethylamino)methyl)-4'-(2-fluoroethoxy-substituted)phenylthio)benzenamine derivatives as potential positron emission tomography imaging agents for serotonin transporters.
    Huang YY; Chang LT; Shen HY; Chen YH; Tzen KY; Shiue CY; Hsin LW
    Bioorg Chem; 2020 Apr; 97():103654. PubMed ID: 32088418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.
    Wang JL; Parhi AK; Oya S; Lieberman B; Kung MP; Kung HF
    Nucl Med Biol; 2008 May; 35(4):447-58. PubMed ID: 18482682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain.
    Zhang Y; Liu F; Xiao H; Yao X; Li G; Choi SR; Ploessl K; Zha Z; Zhu L; Kung HF
    Nucl Med Biol; 2018 Nov; 66():1-9. PubMed ID: 30096380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of the brain serotonin transporters (SERT) with N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) in humans: a preliminary study.
    Huang WS; Huang SY; Ho PS; Ma KH; Huang YY; Yeh CB; Liu RS; Cheng CY; Shiue CY
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):115-24. PubMed ID: 23053324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol prevents hearing loss and a subregion specific- reduction of serotonin reuptake transporter induced by noise exposure in the central auditory system.
    Cheng LQ; Shu FQ; Zhang M; Kai YZ; Tang ZQ
    Front Neurosci; 2023; 17():1134153. PubMed ID: 37034161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.
    Erlandsson K; Sivananthan T; Lui D; Spezzi A; Townsend CE; Mu S; Lucas R; Warrington S; Ell PJ
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of N,N-dimethyl-2-(2-amino-5-[18F]fluorophenylthio)benzylamine (5-[18F]-ADAM) as a serotonin transporter imaging agent.
    Fang P; Shiue GG; Shimazu T; Greenberg JH; Shiue CY
    Appl Radiat Isot; 2004 Dec; 61(6):1247-54. PubMed ID: 15388117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
    Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
    Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts.
    Chiu CH; Li IH; Weng SJ; Huang YS; Wu SC; Chou TK; Huang WS; Liao MH; Shiue CY; Cheng CY; Ma KH
    Cell Transplant; 2016; 25(2):301-11. PubMed ID: 25994923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.